Press Releases

Jeannine Gallagher Jeannine Gallagher

ONC201 FDA drug approval for Diffuse Midline Glioma

FDA grants accelerated approval to dordaviprone (Modeyso, Jazz Pharmaceuticals, Inc.), a protease activator, for adult and pediatric patients 1 year of age and older with diffuse midline glioma harboring an H3 K27M mutation with progressive disease following prior therapy.

Read More